Cikkek nyilvánosan hozzáférhető megbízással - Cosset François-LoïcTovábbi információ
Sehol sem hozzáférhető: 15
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
A Biroccio, J Cherfils-Vicini, A Augereau, S Pinte, S Bauwens, J Ye, ...
Nature cell biology 15 (7), 818-828, 2013
Megbízások: National Health and Medical Research Council, Australia
The mechanism of HCV entry into host cells
F Douam, D Lavillette, FL Cosset
Progress in molecular biology and translational science 129, 63-107, 2015
Megbízások: European Commission
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice
C Lévy, L Aerts, MÈ Hamelin, C Granier, J Szécsi, D Lavillette, G Boivin, ...
Vaccine 31 (25), 2778-2785, 2013
Megbízások: Canadian Institutes of Health Research
Studying HCV cell entry with HCV pseudoparticles (HCVpp)
B Bartosch, FL Cosset
Hepatitis C: methods and protocols, 279-293, 2009
Megbízások: National Institute of Health and Medical Research, France
Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells
C Lévy, E Verhoeyen, FL Cosset
Current opinion in pharmacology 24, 79-85, 2015
Megbízások: European Commission
Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation
VLD Thi, M Dreux, FL Cosset
Expert reviews in molecular medicine 13, e13, 2011
Megbízások: National Institute of Health and Medical Research, France
Gene therapy in Fanconi anemia: a matter of time, safety and gene transfer tool efficiency
E Verhoeyen, F Jose Roman-Rodriguez, FL Cosset, C Levy, P Rio
Current Gene Therapy 16 (5), 297-308, 2016
Megbízások: National Institute of Health and Medical Research, France, European …
Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp)
M Dreux, FL Cosset
Hepatitis C: Methods and Protocols, 427-438, 2009
Megbízások: National Institute of Health and Medical Research, France
Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells
C Costa, G Hypolite, O Bernadin, C Lévy, FL Cosset, V Asnafi, ...
Leukemia 31 (4), 977-980, 2017
Megbízások: National Institute of Health and Medical Research, France
Production of lentiviruses displaying “early-acting” cytokines for selective gene transfer into hematopoietic stem cells
E Verhoeyen, D Nègre, FL Cosset
Gene Therapy Protocols: Design and Characterization of Gene Transfer Vectors …, 2008
Megbízások: National Institute of Health and Medical Research, France
Generation of transgenic mice expressing EGFP protein fused to NP 68 MHC class I epitope using lentivirus vectors
M Tomkowiak, R Ghittoni, M Teixeira, B Blanquier, J Szecsi, D Nègre, ...
genesis 51 (3), 193-200, 2013
Megbízások: National Institute of Health and Medical Research, France
Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients
G Maurin, B Halgand, P Bruscella, J Fresquet, JC Duclos-Vallée, ...
Aids 29 (9), 1025-1033, 2015
Megbízások: European Commission
Membrane fusion assays for studying entry hepatitis C virus into cells
S Denolly, FL Cosset, N Freitas
Hepatitis C Virus Protocols, 219-234, 2019
Megbízások: European Commission, Agence Nationale de la Recherche
Novel lentiviral vector pseudotypes for stable gene transfer into resting hematopoietic cells
ELS VERHOEYEN, FL COSSET
trials 15, 17, 2022
Megbízások: European Commission, Agence Nationale de la Recherche
M1804 Humoral Neutralizing Response to HCV During HIV Coinfection and Liver Transplantation
G Maurin, AM Roque-afonso, P Vaghefi, M Gigou, D Samuel, D Lavillette, ...
Gastroenterology 136 (5), A-842, 2009
Megbízások: US National Institutes of Health
Valahol hozzáférhető: 124
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
T Pietschmann, A Kaul, G Koutsoudakis, A Shavinskaya, S Kallis, ...
Proceedings of the National Academy of Sciences 103 (19), 7408-7413, 2006
Megbízások: German Research Foundation
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana, L Zona, C Davis, ...
Nature medicine 17 (5), 589-595, 2011
Megbízások: US National Institutes of Health, Howard Hughes Medical Institute, National …
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
JM Pestka, MB Zeisel, E Bläser, P Schürmann, B Bartosch, FL Cosset, ...
Proceedings of the National Academy of Sciences 104 (14), 6025-6030, 2007
Megbízások: German Research Foundation
Viral vectors: from virology to transgene expression
D Bouard, N Alazard‐Dany, FL Cosset
British journal of pharmacology 157 (2), 153-165, 2009
Megbízások: National Institute of Health and Medical Research, France
Virology and cell biology of the hepatitis C virus life cycle–An update
J Dubuisson, FL Cosset
Journal of hepatology 61 (1), S3-S13, 2014
Megbízások: European Commission
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.